Home » Gastroenterology: IBD 2011 (Audio-Digest Foundation Gastroenterology Continuing Medical Education (CME). Book 25) by Audio Digest
Gastroenterology: IBD 2011 (Audio-Digest Foundation Gastroenterology Continuing Medical Education (CME). Book 25) Audio Digest

Gastroenterology: IBD 2011 (Audio-Digest Foundation Gastroenterology Continuing Medical Education (CME). Book 25)

Audio Digest

Published
ISBN :
Kindle Edition
17 pages
Enter the sum

 About the Book 

Purpose: Audio-Digest Foundation CME/CE activities are designed to provide its learners – physicians and other healthcare professionals – with continuing education that will help identify clinical problems in their practice settings, provide contentMorePurpose: Audio-Digest Foundation CME/CE activities are designed to provide its learners – physicians and other healthcare professionals – with continuing education that will help identify clinical problems in their practice settings, provide content to help to solve those problems, and increase their application of knowledge to practice.Audio-Digest Gastroenterology is specifically designed to provide the participant with state-of-the-art information, including, but not limited to, procedures and techniques and/or the diagnosis and management of:Inflammatory Bowel DiseaseIrritable Bowel SyndromeGastroesophageal reflux diseaseUlcer diseaseLiver diseasePancreatic diseaseCancer within the digestive systemEndoscopyEsophageal diseaseColon problemsTransplantationNutritionThe goal of this program is to improve the management of inflammatory bowel disease (IBD). After hearing and assimilating this program, the clinician will be better able to:1: Recognize the risk factors for dysplasia in IBD.2: Perform appropriate screening and surveillance for dysplasia in IBD.3: Recommend combination therapy when indicated.4: Elaborate on immunogenicity from therapies used to treat IBD.5: Differentiate between the findings of the Combination of Maintenance Methotrexate-Infliximab Trial (COMMIT) study and the Study of Biologic- and Immunomodulator-Naïve Patients in Crohn’s Disease (SONIC) trial.